- Home
- Products
Brexafemme (Ibrexafungerp)
Brexafemme (Ibrexafungerp)
- Medicine Name: Brexafemme
- Generic Name: Ibrexafungerp
- Dosage Form & Strength: Tablets – 150 mg
- Manufactured By: Scynexis, Inc
Brexafemme is an oral triterpenoid antifungal used for:
- Treatment of Vulvovaginal Candidiasis (VVC) – also known as vaginal yeast infection
- Reduction in recurrence of Recurrent Vulvovaginal Candidiasis (RVVC) in adult and post-menarchal females
FDA-approved and the first non-azole oral antifungal for VVC, Brexafemme offers a novel treatment option for women with limited choices.
Recommended Dosage:
- For VVC Treatment:
Take 2 tablets (300 mg) in the morning and 2 tablets (300 mg) in the evening of the same day (total: 600 mg in one day) - For Prevention of RVVC:
Take 2 tablets (300 mg) in the morning and 2 tablets (300 mg) in the evening on one day per month, for 6 months continuously
Brexafemme can be taken with or without food. Tablets should be swallowed whole with water.
Pregnancy Risk: Contraindicated during pregnancy due to fetal toxicity risk. Confirm pregnancy status before treatment and monthly during RVVC prevention therapy.
Contraception: Use effective contraception during and up to 4 days after the last dose to avoid unintended exposure during pregnancy.
Drug Interactions: Ibrexafungerp may interact with other medications. Inform your doctor about all ongoing treatments.
To import Brexafemme (Ibrexafungerp) 150 mg tablets to India, the following documents are required:
- Valid prescription from a registered doctor
- Diagnostic reports
- Government-issued ID proof
Availability:
Global Rare Meds can supply Brexafemme tablets to major cities in India including Mumbai, Delhi, Bangalore, Chennai, Pune, Hyderabad, Ahmedabad, Kolkata, and more.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds partners with certified international suppliers to import Brexafemme from trusted sources in the USA, Canada, and Europe. Through our fulfillment center in Ambernath, Thane District, we ensure:
- Verified, legally compliant sourcing
- Doorstep delivery with prescription validation
- Quick turnaround time
- 100% transparency in sourcing and cost
Q: What is Brexafemme used for?
A: It is used to treat and reduce recurrence of vaginal yeast infections in adult and adolescent females.
Q: Who manufactures Brexafemme?
A: Scynexis, Inc.
Q: Is Brexafemme FDA approved?
A: Yes. FDA approval was granted on June 1, 2021.
Q: What is the standard dose of Brexafemme?
A:
- 2 tablets (300 mg) in the morning
- 2 tablets (300 mg) in the evening
(Total 600 mg in one day)
Q: What are the common side effects of Brexafemme?
A:
- Nausea
- Loose stools or diarrhea
- Vomiting
- Stomach pain
- Dizziness
Q: What are the storage guidelines?
A:
- Store at 20–25°C (68–77°F)
- Short excursions allowed between 15–30°C (59–86°F)
- Keep in original child-proof blister pack
Q: Is it safe to order Brexafemme online from India?
A: Yes, Global Rare Meds ensures safe and legal import of Brexafemme under Named Patient Program guidelines, with verified documentation and express delivery.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
